Comparison of pain quality descriptors in cancer patients with nociceptive and neuropathic pain

In Vivo

Volumn 21, Issue 1, 2007, Pages 93-98

  Mystakidou, Kyriaki ^a   Parpa, Efi ^a   Tsilika, Eleni ^a   Pathiaki, Maria ^a   Galanos, Antonis ^a   Vlahos, Lambros ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

ECOG; Greek McGill Pain Questionnaire; Neuropathic pain; Nociceptive pain

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ADULT; AGED; ARTICLE; CANCER PAIN; CANCER PATIENT; CONTROLLED STUDY; FEMALE; GREECE; HUMAN; MAJOR CLINICAL STUDY; MALE; MCGILL PAIN QUESTIONNAIRE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEUROPATHIC PAIN; NOCICEPTION; PAIN ASSESSMENT;

EID: 33847661602     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Sella RA, Bruera E, Conner-Spady B, Cumming C and Walker C: Sensory and affective dimensions of advanced cancer pain. Psycho-Oncology 11: 23-34, 2002.
2. Farina S, Tinazzi M, Le Pera D and Valeriani M: Pain-related modulation of the human motor cortex. Neurological Research 25(2): 130-142, 2003.
3. Caumo W, Schmidt AP, Schneider CN, Bergmann J, Iwamoto CW, Adamatti LC, Bandeira D and Ferreira MB: Preoperative predictors of moderate to intense acute postoperative pain in patients undergoing abdominal surgery. Acta Anaesthesiol Scand 46(10): 1265-1271, 2002.
4. Merskey H: Pain terms: a list with definitions and a note on usage. Recommended by the International Association for the Study of Pain (IASP) Subcommittee on Taxonomy. Pain 6: 249-252, 1979.
5. Chapman CR and Gavrin J: Suffering: the contributions to persistent pain. The Lancet 353: 2233-2237, 1999.
6. Porcelli P, Tulipani C, Maiello E, Cilenti G and Todarello O: Alexithymia, coping, and illness behavior correlates of pain experience in cancer patients. Psycho-Oncology, in press, 2006.
7. Shvartzman P, Friger M, Shani A, Barak F, Yoram C and Singer Y: Pain control in ambulatory cancer patients - can we do better? J Pain Sympt Manag 2(26): 716-722, 2003.
8. Duggleby W: The language of pain at the end of life. Pain Manage Nurs 1: 154-160, 2002.
9. Cascinu S, Giordani P, Agostinelli R, Gasparini G, Barni S, Beretta GD, Pulita F, Iacorossi L, Gattuso D, Mare M, Munao S, Labianca R, Todeschini R, Camisa R, Caumo W, Schmidt AP, Schneider CN, Bergmann J, Iwamoto CW, Adamatti LC, Bandeira D and Ferreira MB: Preoperative predictors of moderate to intense acute postoperative pain in patients undergoing abdominal surgery. Acta Anaesthesiol Scand 46(10): 1265-1271, 2002.
10. Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA and Pandya KJ: Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 330: 592-596, 1994.
11. Larue F, Colleau SM, Brasseur L and Cleeland CS: Multicentre study of cancer pain and its treatment in France. BMJ 310: 1034-1037, 1995.
12. Minotti V and Betti M: Attitudes of Italian general practitioners in the treatment of cancer pain. Tumori 83: 729-731, 1997.
13. Portenoy RK: Cancer pain: epidemiology and syndromes. Cancer 63: 2298-2307, 1989.
14. Wang XS, Mendoza TR, Gao SZ and Cleeland CS: The Chinese version of the Brief Pain Inventory (BPI-G): its development and use in a study of cancer pain. Pain 67: 407-416, 1996.
15. Vickers ER, Cousins MJ and Woodhouse A: Pain description and severity of chronic orofacial pain conditions. Aust Dent J 43(6): 403-409, 1998.
16. Cherny NI, Thaler HT, Friedlander-Klar H, Lapin J, Foley KM, Houde R and Portenoy RK: Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies. Neurology 44(5): 857-861, 1994.
17. Bennett M, Smith B, Torrance N and Lee A: Can pain can be more or less neuropathic? Comparison of symptom assessment tools with ratings of certainty by clinicians. Pain 122: 289-294, 2006.
18. Cleeland CS: Measurement of pain by subjective report. In: Advances in Pain Research and Therapy. Chapman CR, Loeser JD (eds.). Volume 12: Issues in Pain Management. New York, Raven Press, pp. 391-403, 1989.
19. Mystakidou K, Mendoza T, Tsilika E, Befon S, Parpa E, Bellos G, Vlahos L and Cleeland C: Greek Brief Pain Inventory: Validation and Utility in Cancer Pain. Oncology 60: 35-42, 2001.
20. Melzack R: The McGill Pain Questionnaire. In: Pain Measurement and Assessment. Melzack R (ed.). New York, Raven, pp. 41-47, 1983.
21. Melzack R: The McGill Pain Questionnaire: major properties and scoring methods. Pain 21: 177-185, 1975.
22. Mystakidou K, Parpa E, Tsilika E, Kalaidopoulou O, Georgaki S, Galanos A and Vlahos L: Greek McGill Pain Questionnaire: validation and utility in cancer patients. J Pain Sympt Manag 24(4): 379-387, 2002.
23. Masson EA, Hunt L, Gem JM and Boulton AJ: A novel approach to the diagnosis and assessment of symptomatic diabetic neuropathy. Pain 38(1): 25-28, 1989.
24. Boureau F, Doubrere JF and Luu M: Study of verbal description in neuropathic pain. Pain 42(2): 145-152, 1990.
25. Wilkie DJ, Savedra MC, Holzemer WL, Tesler MD and Paul SM: Use of the McGill Pain Questionnaire to measure pain: a meta-analysis. Nurs Res 39(1): 36-41, 1990.
26. Wilkie DJ, Huang HY, Reilly N and Cain KC: Nociceptive and neuropathic pain in patients with lung cancer: A comparison of pain quality descriptors. J Pain Sympt Manag 22(5): 899-910, 2001.
27. Tearnan J, Blake H and Cleeland CS: Unaided use of pain descriptors by patients with cancer pain. J Pain Symtom Manage 5: 228-232, 1990.
28. Bennett GJ. Neuropathic pain. In: Textbook of Pain. Melzack R, Wall PD (eds.). Edinburgh, Churchill Livingstone, pp. 201-224, 1994.
29. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET and Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5: 649-655Y, 1982.
30. Mystakidou K, Parpa E, Tsilika E, Mavromati A, Smyrniotis V, Georgaki S and Vlahos L: Long-term management noncancer pain with Transdermal Therapeutic System-Fentanyl. Pain 4(6): 298-306, 2003.
31. Asbury AK and Fields HL: Pain due to peripheral nerve damage: a hypothesis. Neurology 34: 1587-1590, 1984.
32. Tasker RR: Deafferentiation pain syndromes: introduction. In: Differentiation Pain Syndromes: Pathophysiology and Treatment. Nashold BS, Ovelman-Levit J (eds.). New York, Raven Press, pp. 241-257, 1991.
33. Martin LE and Hagen NA: Neuropathic pain in cancer patients: mechanisms, syndromes, and clinical controversies. J Pain Sympt Manag 14(2): 99-117, 1997.
34. Au E, Loprinzi CL, Dhodapkar M, Nelson T, Novotny P, Hammack J and O'Fallon J: Regular use of a verbal scale improves the understanding of oncology in patient's pain intensity. J Clin Oncol 12(12): 2751-2755, 1994.
35. Jensen M, Dworkin R, Gammaitoni A, Olaleye D, Oleka N and Galer B: Do pain qualities and spatial characteristics make independent contributions to interference with physical and emotional functioning? J Pain 7(9): 644-653, 2006.
36. Charter RA and Nehemkis AM: The language of pain intensity and complexity: new methods of scoring the McGill Pain Questionnaire. Percep Motor Skills 56: 519-537, 1983.
37. Marques AP, Rhoden L, Siqueira JO and Joao SMA: Pain evaluation of patients with fibromyalgia, osteoarthritis, and low back pain. Rev Hosp Clin Fac Med S Paulo 56: 5-10, 2001.